metabolic profiling of Parkinson's disease and mild cognitive impairment

Background: Early diagnosis of Parkinson's disease and mild cognitive impairment is important to enable prompt treatment and improve patient welfare, yet no standard diagnostic test is available. Metabolomics is a powerful tool used to elucidate disease mechanisms and identify potential biomark...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Mov Disord
Autors principals: Burté, Florence, Houghton, David, Lowes, Hannah, Pyle, Angela, Nesbitt, Sarah, Yarnall, Alison, Yu‐Wai‐Man, Patrick, Burn, David J., Santibanez‐Koref, Mauro, Hudson, Gavin
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2017
Matèries:
Brief Reports
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5485028/
https://ncbi.nlm.nih.gov/pubmed/28394042
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/mds.26992
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars